Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Tissue Proteins | 8 | 2022 | 34 | 3.860 |
Why?
|
| Phorbol Esters | 9 | 2023 | 9 | 3.180 |
Why?
|
| Protein Kinase C-alpha | 7 | 2023 | 7 | 3.120 |
Why?
|
| Curcumin | 6 | 2021 | 10 | 2.450 |
Why?
|
| Ethanol | 7 | 2022 | 45 | 2.280 |
Why?
|
| Protein Kinase C | 7 | 2023 | 15 | 2.250 |
Why?
|
| Protein Kinase C-epsilon | 5 | 2016 | 5 | 2.140 |
Why?
|
| Molecular Dynamics Simulation | 6 | 2023 | 32 | 1.970 |
Why?
|
| Diglycerides | 3 | 2023 | 6 | 1.910 |
Why?
|
| Alcoholism | 3 | 2024 | 42 | 1.690 |
Why?
|
| Binding Sites | 14 | 2023 | 66 | 1.660 |
Why?
|
| Stilbenes | 4 | 2017 | 6 | 1.390 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 10 | 1.380 |
Why?
|
| Molecular Docking Simulation | 9 | 2023 | 27 | 1.350 |
Why?
|
| Animals | 16 | 2024 | 1711 | 1.310 |
Why?
|
| Protein Binding | 10 | 2023 | 115 | 1.250 |
Why?
|
| Alcohols | 3 | 2015 | 5 | 1.160 |
Why?
|
| SNARE Proteins | 2 | 2019 | 5 | 1.160 |
Why?
|
| Neurons | 3 | 2019 | 109 | 1.150 |
Why?
|
| Ligands | 5 | 2023 | 55 | 1.130 |
Why?
|
| Protein Structure, Tertiary | 7 | 2023 | 30 | 1.130 |
Why?
|
| Neoplasms | 2 | 2021 | 90 | 1.050 |
Why?
|
| Protein Domains | 4 | 2021 | 18 | 0.970 |
Why?
|
| Synaptic Transmission | 3 | 2022 | 13 | 0.940 |
Why?
|
| Diazomethane | 2 | 2018 | 2 | 0.930 |
Why?
|
| Photoaffinity Labels | 2 | 2018 | 2 | 0.930 |
Why?
|
| Humans | 16 | 2024 | 4936 | 0.930 |
Why?
|
| Mitragyna | 1 | 2024 | 1 | 0.890 |
Why?
|
| Proteins | 2 | 2018 | 46 | 0.890 |
Why?
|
| Models, Molecular | 8 | 2019 | 82 | 0.870 |
Why?
|
| Pyrazoles | 2 | 2015 | 19 | 0.810 |
Why?
|
| Alcohol Drinking | 2 | 2022 | 102 | 0.790 |
Why?
|
| Presynaptic Terminals | 2 | 2020 | 3 | 0.790 |
Why?
|
| Mass Spectrometry | 3 | 2018 | 20 | 0.760 |
Why?
|
| Central Nervous System Depressants | 2 | 2020 | 7 | 0.750 |
Why?
|
| Mice | 7 | 2022 | 685 | 0.730 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 12 | 0.720 |
Why?
|
| Isoenzymes | 4 | 2014 | 11 | 0.690 |
Why?
|
| Anesthetics, Dissociative | 1 | 2020 | 1 | 0.660 |
Why?
|
| Drug Repositioning | 1 | 2020 | 2 | 0.660 |
Why?
|
| Polyphenols | 2 | 2021 | 8 | 0.660 |
Why?
|
| Ketamine | 1 | 2020 | 3 | 0.660 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 14 | 0.650 |
Why?
|
| Synaptic Membranes | 1 | 2020 | 1 | 0.650 |
Why?
|
| Protein Kinase C-theta | 2 | 2018 | 2 | 0.650 |
Why?
|
| Tryptophan | 2 | 2018 | 2 | 0.650 |
Why?
|
| Antioxidants | 2 | 2021 | 23 | 0.650 |
Why?
|
| Amino Acid Sequence | 6 | 2018 | 49 | 0.640 |
Why?
|
| Bryostatins | 1 | 2019 | 1 | 0.610 |
Why?
|
| Drug Design | 2 | 2016 | 16 | 0.600 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 14 | 0.550 |
Why?
|
| Chemistry, Organic | 1 | 2017 | 3 | 0.540 |
Why?
|
| Faculty, Pharmacy | 1 | 2017 | 11 | 0.540 |
Why?
|
| Perception | 1 | 2017 | 32 | 0.530 |
Why?
|
| Mutation | 5 | 2020 | 132 | 0.520 |
Why?
|
| Curriculum | 1 | 2017 | 48 | 0.520 |
Why?
|
| Students, Pharmacy | 1 | 2017 | 73 | 0.480 |
Why?
|
| Protein Kinase C beta | 1 | 2015 | 3 | 0.480 |
Why?
|
| Protein Transport | 4 | 2018 | 30 | 0.480 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 25 | 0.460 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2013 | 2 | 0.400 |
Why?
|
| Enzyme Activators | 1 | 2013 | 1 | 0.400 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 46 | 0.390 |
Why?
|
| Fatty Acids | 1 | 2012 | 10 | 0.380 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 45 | 0.380 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2018 | 5 | 0.380 |
Why?
|
| Protein Conformation | 3 | 2020 | 43 | 0.370 |
Why?
|
| Amino Acid Substitution | 3 | 2018 | 16 | 0.370 |
Why?
|
| Lipids | 2 | 2023 | 20 | 0.370 |
Why?
|
| Isoxazoles | 1 | 2011 | 1 | 0.360 |
Why?
|
| Kinetics | 3 | 2016 | 80 | 0.320 |
Why?
|
| HEPES | 1 | 2009 | 1 | 0.300 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 2 | 0.300 |
Why?
|
| Cell Survival | 3 | 2016 | 54 | 0.300 |
Why?
|
| Tromethamine | 1 | 2009 | 2 | 0.300 |
Why?
|
| Octanols | 1 | 2009 | 3 | 0.300 |
Why?
|
| Synapses | 2 | 2019 | 10 | 0.300 |
Why?
|
| Hippocampus | 2 | 2022 | 59 | 0.300 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2013 | 14 | 0.270 |
Why?
|
| Protein Structure, Secondary | 2 | 2019 | 22 | 0.260 |
Why?
|
| Cell Membrane | 2 | 2018 | 48 | 0.250 |
Why?
|
| Microscopy, Confocal | 2 | 2016 | 49 | 0.240 |
Why?
|
| Alkaloids | 1 | 2024 | 9 | 0.220 |
Why?
|
| Enzyme Activation | 2 | 2016 | 13 | 0.220 |
Why?
|
| CHO Cells | 2 | 2016 | 17 | 0.220 |
Why?
|
| Cricetulus | 2 | 2016 | 18 | 0.220 |
Why?
|
| Drosophila | 2 | 2022 | 25 | 0.210 |
Why?
|
| HEK293 Cells | 2 | 2016 | 30 | 0.210 |
Why?
|
| Recombinant Proteins | 2 | 2018 | 23 | 0.210 |
Why?
|
| Lactones | 1 | 2023 | 10 | 0.200 |
Why?
|
| Signal Transduction | 2 | 2016 | 216 | 0.190 |
Why?
|
| Structure-Activity Relationship | 2 | 2012 | 44 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 2 | 0.170 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2011 | 20 | 0.170 |
Why?
|
| Nerve Net | 1 | 2020 | 25 | 0.160 |
Why?
|
| Depressive Disorder, Major | 1 | 2020 | 17 | 0.160 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2010 | 7 | 0.150 |
Why?
|
| Heterozygote | 1 | 2019 | 8 | 0.150 |
Why?
|
| Cell Line | 1 | 2019 | 84 | 0.150 |
Why?
|
| Cells, Cultured | 1 | 2019 | 127 | 0.150 |
Why?
|
| Male | 3 | 2022 | 2491 | 0.140 |
Why?
|
| Hypnotics and Sedatives | 1 | 2018 | 10 | 0.140 |
Why?
|
| Brain | 1 | 2020 | 195 | 0.140 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2018 | 2 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 9 | 0.140 |
Why?
|
| Mutant Proteins | 1 | 2018 | 5 | 0.140 |
Why?
|
| Drosophila Proteins | 1 | 2018 | 30 | 0.140 |
Why?
|
| Education, Pharmacy, Graduate | 1 | 2017 | 5 | 0.140 |
Why?
|
| Neuroblastoma | 1 | 2018 | 12 | 0.140 |
Why?
|
| Membrane Proteins | 1 | 2018 | 47 | 0.130 |
Why?
|
| Free Radical Scavengers | 1 | 2017 | 3 | 0.130 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 7 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 81 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2017 | 49 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 160 | 0.130 |
Why?
|
| Binding, Competitive | 1 | 2016 | 6 | 0.130 |
Why?
|
| Immunoblotting | 1 | 2016 | 8 | 0.130 |
Why?
|
| Biocatalysis | 1 | 2016 | 4 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 9 | 0.130 |
Why?
|
| Rats | 1 | 2018 | 241 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 33 | 0.120 |
Why?
|
| Lipoylation | 1 | 2016 | 1 | 0.120 |
Why?
|
| Methylation | 1 | 2016 | 6 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 6 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 6 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 10 | 0.120 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 258 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2016 | 48 | 0.120 |
Why?
|
| Education, Pharmacy | 1 | 2017 | 73 | 0.120 |
Why?
|
| Patents as Topic | 1 | 2015 | 2 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2015 | 5 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 35 | 0.110 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2015 | 11 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 32 | 0.110 |
Why?
|
| Sequence Alignment | 1 | 2014 | 16 | 0.110 |
Why?
|
| Pliability | 1 | 2014 | 2 | 0.110 |
Why?
|
| Thermodynamics | 1 | 2014 | 43 | 0.100 |
Why?
|
| Water | 1 | 2014 | 38 | 0.100 |
Why?
|
| Circular Dichroism | 1 | 2013 | 6 | 0.100 |
Why?
|
| Photochemistry | 1 | 2013 | 5 | 0.100 |
Why?
|
| Self Administration | 1 | 2013 | 7 | 0.100 |
Why?
|
| Fluorescence | 1 | 2013 | 14 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2013 | 23 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2013 | 20 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2013 | 7 | 0.100 |
Why?
|
| Cricetinae | 1 | 2012 | 21 | 0.100 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2011 | 2 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2013 | 111 | 0.090 |
Why?
|
| Models, Biological | 1 | 2012 | 124 | 0.090 |
Why?
|
| Stereoisomerism | 1 | 2011 | 21 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 52 | 0.090 |
Why?
|
| Photolysis | 1 | 2011 | 3 | 0.090 |
Why?
|
| Molecular Structure | 1 | 2011 | 84 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2009 | 27 | 0.080 |
Why?
|
| Anesthetics | 1 | 2009 | 1 | 0.080 |
Why?
|
| Buffers | 1 | 2009 | 6 | 0.070 |
Why?
|
| Crystallization | 1 | 2009 | 83 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 44 | 0.070 |
Why?
|
| Time Factors | 1 | 2009 | 163 | 0.070 |
Why?
|
| Female | 2 | 2019 | 2523 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2019 | 4 | 0.040 |
Why?
|
| Spatial Learning | 1 | 2019 | 6 | 0.040 |
Why?
|
| Motor Activity | 1 | 2019 | 61 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2019 | 140 | 0.040 |
Why?
|
| Synaptic Vesicles | 1 | 2018 | 4 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 184 | 0.040 |
Why?
|
| Anxiety | 1 | 2019 | 167 | 0.030 |
Why?
|